Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Seelos Therapeutics Inc (SEEL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Seelos Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.332 -0.053    -13.79%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.360
+0.028
+8.434%
19:59:45 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 715,704
  • Bid/Ask: 0.350 / 0.382
  • Day's Range: 0.331 - 0.398
Seelos Therapeutics 0.332 -0.053 -13.79%

Seelos Therapeutics Inc Company Profile

 
Get an in-depth profile of Seelos Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

16

Equity Type

ORD

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The Company operates under one segment which develops pharmaceutical products. The Company's programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA). SLS-002 is intranasal racemic ketamine with two investigational new drug applications (INDs). SLS-005 is used for the potential treatment of Sanfilippo Syndrome. SLS-005 is IV trehalose, a protein stabilizer that crosses the blood-brain barrier and activates autophagy and the lysosomal pathway. The Company's ongoing programs include SLS-004, SLS-006, and SLS-007.

Contact Information

Address 300 Park Avenue 2nd Floor
New York, 10022
United States
Phone 646 293 2100
Fax -

Top Executives

Name Age Since Title
Raj Mehra 62 2019 Founder, Chairman, CEO & President
Richard W. Pascoe 58 2013 Independent Director
Brian Lian 56 2019 Independent Director
Daniel J. O'Connor 57 2019 Independent Director
Margaret R. Dalesandro 75 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SEEL Comments

Write your thoughts about Seelos Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
TechTrend Trades
TechTrend Trades Oct 30, 2023 3:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy in Jan/Feb
Yogi Bear
Yogi Bear Oct 30, 2023 3:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well, TTT, that comment, as many others you have posted, did not age well.
Falah Alshaikh
Falah Alshaikh Jul 27, 2021 1:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
money is on the way
Manish Agarwal
Manish Agarwal May 18, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi Fellow investors- do you know why SEEL is falling daily. pls share your views
Eric Grant
Eric Grant May 18, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Based on 2 analysts offering 12 month price targets for Seelos Therapeutics Inc.
Eric Grant
Eric Grant May 18, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The consensus among 2 Wall Street analysts covering (NASDAQ: SEEL) stock is to Strong Buy SEEL stock.
Manish Agarwal
Manish Agarwal May 18, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi Fellow investors- any particular reason this is falling everyday: SEEL
Simon Hemmes
SimonGiraf Apr 27, 2021 11:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
An ATH today.
Red Boston
Red Boston Apr 23, 2021 11:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon 8- 9$
Hemant Thakker
Hemant Thakker Apr 09, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I want to invest in this company but stock price looks extended.. any one with suggestions is it buy?...
Jean Baubine
Jean Baubine Apr 09, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought last year at 0.55c .. no way its a buy a this price
Jean Baubine
Jean Baubine Apr 09, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought last year at 0.55c .. no way its a buy a this price
Jean Baubine
Jean Baubine Apr 09, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought last year at 0.55c .. no way its a buy, at this price
Mark Belmont
Mark Belmont Apr 09, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jean Baubine Good job dude. But now that it has viable fda prospects I could see it going to 8.50
Mark Belmont
Mark Belmont Apr 09, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well done. Although now that it has viable fda prospects I could see it going to 8.50
Frank Lied
Frank Lied Apr 08, 2021 5:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Keeps going up in overtime.....⤴️
ptv Marco
ptv Marco Apr 06, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thougths?
Frank Lied
Frank Lied Apr 06, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target for the stock is set at $15 I'm thinking that's what I want.
ptv Marco
ptv Marco Apr 06, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Saw that!
JAH Ann
JAH Ann Mar 25, 2021 1:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I dont see why this cant be $7 soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email